Mayuko Ikarashi

The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)

Nobumoto Tomioka, Manabu Azuma, Mayuko Ikarashi et al. · Breast Cancer · 2017 · 105 citations

Medicine, Immunology, Oncology +17

Low fat-containing elemental formula is effective for postoperative recovery and potentially useful for preventing chyle leak during postoperative early enteral nutrition after esophagectomy

Kazuki Moro, Yu Koyama, Shin‐ichi Kosugi et al. · Clinical Nutrition · 2016 · 23 citations · Full text

Medicine, Nutritional Sciences, Surgery +17

Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer

Chie Toshikawa, Yu Koyama, Masayuki Nagahashi et al. · Journal of Clinical Medicine Research · 2015 · 19 citations · Full text

Medicine, Oncology, Surgery +16

Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer

Mayuko Ikarashi, Junko Tsuchida, Masayuki Nagahashi et al. · International Journal of Molecular Sciences · 2021 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

Left colic artery aneurysm rupture after stent placement for abdominal aortic aneurysm associated with neurofibromatosis type 1

Kazuki Moro, Hitoshi Kameyama, Kaoru Abe et al. · Surgical Case Reports · 2019 · 12 citations · Full text

Medicine, Pathology, Anatomic Pathology +14